Pegloticase - Horizon Therapeutics
At a glance
- Drug Originator Duke University; Mountain View Pharmaceuticals
- Drug Licenced by Horizon Therapeutics plc
- Drug Class Antigouts; Oxidoreductases; Polyethylene glycols; Recombinant proteins
- Mechanism of Action Urate oxidase replacements
- USA Patent Applicants HORIZON PHARMA
- USA Patents 1
- BLAs 1
Table of Contents
Disclaimer